epanolol

Epanolol is a selective beta-1 adrenergic receptor partial agonist and antagonist, classified as a beta blocker. It is primarily used as an antianginal agent for the treatment of angina pectoris and has also been explored for managing hypertension. Epanolol exhibits about 20–25% of the agonist activity of the full agonist isoprenaline, resulting in minimal reductions in heart rate and blood pressure at rest but effective attenuation of heart rate and systolic blood pressure during exercise. This pharmacological profile makes it effective in reducing angina attacks while maintaining tolerability, with fewer side effects compared to full beta-blockers. Epanolol is typically administered once daily due to its long duration of action[1][3][4][6][8].